Search Results - "KALECHMAN, Y"

The tellurium‐based immunomodulator, AS101 ameliorates adjuvant‐induced arthritis in rats by Halpert, G., Halperin Sheinfeld, M., Monteran, L., Sharif, K., Volkov, A., Nadler, R., Schlesinger, A., Barshak, I., Kalechman, Y., Blank, M., Shoenfeld, Y., Amital, H.

“…We report an anti‐rheumatic/inflammatory activity of the non‐toxic, tellurium‐based immunomodulatory compound AS101 in experimental RA by reducing disease…”
Get full text

Modulation of the IL‐2 production defect in vitro in Graves’disease by EISENSTEIN, Z., ENGELSMAN, E., WEISS, M., KALECHMAN, Y., SREDNI, B.

“…SUMMARY IL‐2 production by mitogen‐induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including…”
Get full text

Tellurium Compound AS101 Induces PC12 Differentiation and Rescues the Neurons from Apoptotic Death by MAKAROVSKY, D, KALECHMAN, Y, SONINO, T, FREIDKIN, I, TEITZ, S, ALBECK, M, WEIL, M, GEFFEN-ARICHA, R, YADID, G, SREDNI, B

“…: Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra (SN). Studies show that anti‐apoptotic and neurotrophic…”
Get full text

Role of Endogenous Cytokines Secretion in Radioprotection Conferred by the Immunomodulator Ammonium Trichloro(dioxyethylene-0-0')tellurate by Kalechman, Y., Zuloff, A., Albeck, M., Strassmann, G., Sredni, B.

“…The immunomodulator ammonium trichloroldioxyethylene-0-0'Itellurate (AS101) has previously been found by us to have radioprotective properties when injected…”
Get full text

Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide by Sredni, B, Albeck, M, Tichler, T, Shani, A, Shapira, J, Bruderman, I, Catane, R, Kaufman, B, Kalechman, Y

“…The aim of this study was to evaluate the ability of the immunomodulator AS101 to prevent chemotherapy-induced neutropenia and thrombocytopenia and thus allow…”
Get more information

Induction of a subpopulation of suppressor cells by a single blood transfusion by Gafter, Uzi, Kalechman, Yona, Sredni, Benjamin

“…Induction of a subpopulation of suppressor cells by a single blood transfusion. Blood transfusion induces immunosuppression by a mechanism which is probably…”
Get full text

A new immunomodulating compound (AS-101) with potential therapeutic application by Sredni, B, Caspi, R. R, Klein, A, Kalechman, Y, Danziger, Y, BenYa'akov, M, Tamari, T, Shalit, F, Albeck, M

“…There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action. Direct administration of…”
Get full text

Tubulointerstitial nephritis and uveitis: association with suppressed cellular immunity by Gafter, U, Kalechman, Y, Zevin, D, Korzets, A, Livni, E, Klein, T, Sredni, B, Levi, J

“…It is suggested that tubulointerstitial nephritis and uveitis (TINU) is a cell-mediated immune disease with a favourable response to treatment with steroids…”
Get more information

The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma by Kalechman, Y, Shani, A, Dovrat, S, Whisnant, JK, Mettinger, K, Albeck, M, Sredni, B

“…The immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate (AS101) has been shown to possess antitumoral properties in several murine models. In the…”
Get full text

The effect of a single whole-blood transfusion on cytokine secretion by KALECHMAN, Y, GAFTER, U, SOBELMAN, D, SREDNI, B

“…The effect of a single whole-blood transfusion on the cascade of cytokine secretion was studied in patients with chronic renal failure. The results indicate…”
Get full text

Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice by Kalechman, Y, Rushkin, G, Nerubay, J, Albeck, M, Sredni, B

“…The immunomodulator AS101 has previously been found to induce mouse and human hematopoietic cells to secrete cytokines such as interleukin-1 alpha (IL-1…”
Get more information

Immunization with WBC suppresses T cells and NK Activity in vitro by Gafter, U., Sredni, B., Segal, J., Kalechman, Y.

Get full text

Immunization with WBC induces monocyte suppression Activity in vitro by Gafter, U., Sredni, B., Segal, J., Kalechman, Y.

Get full text

In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin by Kalechman, Y, Albeck, M, Sredni, B

“…The immunomodulator AS101 has recently been found to have radioprotective properties when injected prior to sublethal and lethal doses of irradiation. In…”
Get more information

Modulation of the IL-2 production defect in vitro in Grave's disease by EISENSTEIN, Z, ENGELSMAN, E, WEISS, M, KALECHMAN, Y, SREDNI, B

“…IL-2 production by mitogen-induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including Graves' disease…”
Get full text

Synergism between AS101 and PMA in lymphokine production by SREDNI, B, KALECHMAN, Y, SHALIT, F, ALBECK, M

“…AS101 [ammonium trichloro (dioxyethylene-o-o') tellurate] has been reported to stimulate normal mouse and human lymphoid cells to proliferate and to produce…”
Get full text

The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment by Kalechman, Y, Sotnik-Barkai, I, Albeck, M, Sredni, B

“…AS101 (ammonium trichloro[dioxyethylene-O-O']tellurate) is a new synthetic compound previously described by us as having immunomodulating properties and…”
Get more information

Radioprotective effects of the immunomodulator AS101 by Kalechman, Y, Albeck, M, Oron, M, Sobelman, D, Gurwith, M, Seghal, SN, Sredni, B

“…Ammonium trichloro(dioxyethylene-O-O')tellurate (AS101) is a new synthetic compound previously described by us as having immunomodulating properties and…”
Get full text

Mechanism of radioprotection conferred by the immunomodulator AS101 by Kalechman, Y, Gafter, U, Barkai, I S, Albeck, M, Sredni, B

“…AS101 [ammonium trichloro (dioxyethylene-0-0') tellurate] is a new synthetic compound previously described by us as having immunomodulating properties and…”
Get more information

Generation of T cell lines with suppressive activity derived from autorosette-forming cells of patients with autoimmune diseases by Kalechman, Y, Michlin, H, Gafter, U, Sredni, B

“…A unique subpopulation of human suppressor autorosette-forming T cells was fractionated from peripheral blood of healthy donors and patients with various…”
Get more information